Printer Friendly
The Free Library
14,635,145 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cook Zilver Stent Receives FDA Approval for Vascular Use.


BLOOMINGTON, Ind. -- In a milestone achievement for the company, Cook Incorporated has received U.S. Food and Drug Administration approval to market its Zilver Vascular Stent for use treating symptomatic vascular disease of the iliac arteries, the most common type of vascular disease.

"Peripheral vascular disease Peripheral Vascular Disease Definition

Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms.
 is a major health issue affecting millions of patients in the U.S. alone. Until recently, physicians have had limited options in treating vascular disease in the iliac arteries. But with this FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approval, we now have an advanced stent design that can significantly aid patients with this condition," explained Barry Katzen, M.D., Medical Director of Baptist Cardiac and Vascular Institute, Miami, Fl. Dr. Katzen was primary investigator for the pivotal U.S. trial of the Zilver Vascular Stent.

"Cook's goal is to become the world leader in therapeutic technologies for the peripheral arteries," explained Rob Lyles, global leader of Cook's diagnostic and interventional products division. "Receiving FDA approval to sell our Zilver Vascular Stent system is a huge step for Cook toward that goal, and we look forward to building on the success we've already achieved in this area as we bring physicians another critical advance in treating peripheral vascular disease."

The indication is the first FDA approval for vascular use of Cook's Zilver stent, a self-expanding nitinol device. Cook has regulatory approval to market the stent for vascular use in more than 25 countries, including Australia, Brazil, France, Germany, the United Kingdom, India, China, Taiwan, and others. Cook's submission to the FDA was supported by data from a 20-patient pilot study and a pivotal study evaluating 151 patients at 24 U.S. investigational sites.

Cook's Zilver Vascular Stent is indicated for use in the treatment of symptomatic vascular disease of the iliac arteries with a reference vessel diameter of 5 mm to 9 mm. The stent may be used to treat lesions up to 100 mm in length, according to the FDA indications.

The world's largest privately held manufacturer of medical devices with international headquarters in Bloomington, Ind., COOK(R) (www.cookmedical.com/) is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, Cook has created innovative technologies for drug-eluting and bare metal stents, aortic aortic

pertaining to or emanating from the aorta. See also aortic arch.


aortic aneurysm
occurs most often in dogs, where it is caused by Spirocerca lupi larvae, turkeys and primates, causing dyspnea, cyanosis and coughing.
 and vascular endografts, catheters, wire guides, introducer needles and sheaths, embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun)
1. the process or condition of becoming an embolus.

2. therapeutic introduction of a substance into a vessel in order to occlude it.
 coils, medical biomaterials and contract manufacturing of biopharmaceuticals, vena cava filters Vena Cava Filter Definition

A vena cava filter is a device inserted into a major vein to prevent a blood clot from entering the lungs.
Purpose
 and other minimally invasive medical devices for radiology, cardiology, urology urology

Medical specialty dealing with the urinary system and male reproductive organs. It traces its origin to medieval lithologists, itinerant healers who specialized in surgical removal of bladder stones.
 and women's health Women's Health Definition

Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues.
, critical care medicine, surgery, gastroenterology gastroenterology

Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833.
, bone access and endovascular therapies.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 5, 2006
Words:423
Previous Article:American Science and Engineering, Inc. Receives $2.3 Million Follow-on Order for Multiple ZBVs from a Middle Eastern Country; ZBVs to be Utilized by...
Next Article:Pluristem Announces Breakthrough in Bone Marrow Transplants: Engrafted Cells Increase 2-4 Times in Preclinical Study.
Topics:



Related Articles
Cook Launches Web Site for Patients Seeking Information About Peripheral Arterial Disease; Site Provides Information About Drug-Coated Stent in...
Medtronic Submits First PMA Module to the U.S. Food and Drug Administration for Endeavor(TM) Drug-Eluting Coronary Stent; Module Submission is First...
Medtronic Announces First Clinical Trial Experience with Next-Generation Drug-Eluting Coronary Stent System.
Guidant Enrolls First Patient in Japan Arm of Drug Eluting Stent Trial; SPIRIT III U.S. Randomized Enrollment Passes Halfway Mark.
Endologix Announces Limited Voluntary Recall of Powerlink System Delivery Catheter; Recall Does Not Involve Devices Implanted in Patients; Scheduled...
Guidant Receives Recommendation for Approval from European Competent Authority for Drug Eluting Stent; Company Has Successfully Completed Conformity...
Medtronic Announces Regulatory Approval in China for the Endeavor(R) Drug-Eluting Coronary Stent System.
Medtronic Announces Completion of Patient Enrollment in ENDEAVOR IV Clinical Trial; Enrollment Also Complete in ENDEAVOR-Japan and RESOLUTE Clinical...
Medtronic Achieves Key Milestones in Rapidly Growing Peripheral Vascular Business.
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles